Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-025104
Filing Date
2019-04-17
Accepted
2019-04-17 17:52:59
Documents
1
Period of Report
2019-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 8626
  Complete submission text file 0001209191-19-025104.txt   9939
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Parschauer Karah Herdman (Reporting) CIK: 0001677455 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36276 | Film No.: 19753891